Annual CFO
$118.96 M
+$150.16 M+481.24%
31 December 2023
Summary:
ANI Pharmaceuticals annual cash flow from operations is currently $118.96 million, with the most recent change of +$150.16 million (+481.24%) on 31 December 2023. During the last 3 years, it has risen by +$103.69 million (+679.19%). ANIP annual CFO is now at all-time high.ANIP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$12.47 M
-$4.94 M-28.37%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly cash flow from operations is currently $12.47 million, with the most recent change of -$4.94 million (-28.37%) on 30 September 2024. Over the past year, it has dropped by -$19.70 million (-61.22%). ANIP quarterly CFO is now -72.12% below its all-time high of $44.74 million, reached on 31 December 2023.ANIP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$92.90 M
-$19.70 M-17.49%
30 September 2024
Summary:
ANI Pharmaceuticals TTM cash flow from operations is currently $92.90 million, with the most recent change of -$19.70 million (-17.49%) on 30 September 2024. Over the past year, it has increased by +$23.08 million (+33.05%). ANIP TTM CFO is now -21.91% below its all-time high of $118.96 million, reached on 31 December 2023.ANIP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +481.2% | -61.2% | +33.0% |
| 3 y3 years | +679.2% | +330.9% | +848.1% |
| 5 y5 years | +77.3% | -42.8% | +36.5% |
ANIP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +481.2% | -72.1% | +165.8% | -21.9% | +293.5% |
| 5 y | 5 years | at high | +481.2% | -72.1% | +165.8% | -21.9% | +293.5% |
| alltime | all time | at high | +348.5% | -72.1% | +165.8% | -21.9% | +281.6% |
ANI Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.47 M(-28.4%) | $92.90 M(-17.5%) |
| June 2024 | - | $17.41 M(-4.7%) | $112.59 M(-2.8%) |
| Mar 2024 | - | $18.27 M(-59.2%) | $115.80 M(-2.7%) |
| Dec 2023 | $118.96 M(-481.2%) | $44.74 M(+39.1%) | $118.96 M(+70.4%) |
| Sept 2023 | - | $32.17 M(+56.0%) | $69.82 M(+69.2%) |
| June 2023 | - | $20.63 M(-3.7%) | $41.27 M(+350.4%) |
| Mar 2023 | - | $21.42 M(-586.9%) | $9.16 M(-129.4%) |
| Dec 2022 | -$31.20 M(-1039.3%) | -$4.40 M(-221.4%) | -$31.20 M(-20.0%) |
| Sept 2022 | - | $3.62 M(-131.5%) | -$38.99 M(-18.8%) |
| June 2022 | - | -$11.48 M(-39.4%) | -$48.01 M(+32.3%) |
| Mar 2022 | - | -$18.94 M(+55.5%) | -$36.29 M(-1192.4%) |
| Dec 2021 | $3.32 M(-78.2%) | -$12.19 M(+125.6%) | $3.32 M(-66.1%) |
| Sept 2021 | - | -$5.40 M(-2341.5%) | $9.80 M(-27.9%) |
| June 2021 | - | $241.00 K(-98.8%) | $13.59 M(-60.3%) |
| Mar 2021 | - | $20.67 M(-462.0%) | $34.23 M(+124.2%) |
| Dec 2020 | $15.27 M(-66.5%) | -$5.71 M(+253.7%) | $15.27 M(-40.8%) |
| Sept 2020 | - | -$1.61 M(-107.7%) | $25.78 M(-47.6%) |
| June 2020 | - | $20.88 M(+1121.1%) | $49.19 M(+48.8%) |
| Mar 2020 | - | $1.71 M(-64.4%) | $33.05 M(-27.6%) |
| Dec 2019 | $45.63 M(-32.0%) | $4.80 M(-78.0%) | $45.63 M(-33.0%) |
| Sept 2019 | - | $21.79 M(+359.4%) | $68.06 M(+24.7%) |
| June 2019 | - | $4.74 M(-66.8%) | $54.59 M(-6.6%) |
| Mar 2019 | - | $14.29 M(-47.5%) | $58.44 M(-12.9%) |
| Dec 2018 | $67.07 M(+70.2%) | $27.23 M(+227.3%) | $67.07 M(+20.5%) |
| Sept 2018 | - | $8.32 M(-3.2%) | $55.65 M(-13.6%) |
| June 2018 | - | $8.59 M(-62.5%) | $64.41 M(+15.4%) |
| Mar 2018 | - | $22.93 M(+45.1%) | $55.82 M(+41.6%) |
| Dec 2017 | $39.42 M(+43.5%) | $15.80 M(-7.5%) | $39.42 M(+10.4%) |
| Sept 2017 | - | $17.08 M(>+9900.0%) | $35.70 M(+81.2%) |
| June 2017 | - | $1000.00(-100.0%) | $19.70 M(-14.5%) |
| Mar 2017 | - | $6.53 M(-46.0%) | $23.03 M(-16.2%) |
| Dec 2016 | $27.47 M(+59.1%) | $12.08 M(+1014.6%) | $27.47 M(+36.7%) |
| Sept 2016 | - | $1.08 M(-67.5%) | $20.09 M(-31.3%) |
| June 2016 | - | $3.34 M(-69.6%) | $29.24 M(+7.9%) |
| Mar 2016 | - | $10.97 M(+133.3%) | $27.11 M(+57.0%) |
| Dec 2015 | $17.26 M(-21.6%) | $4.70 M(-54.1%) | $17.26 M(-25.9%) |
| Sept 2015 | - | $10.24 M(+748.8%) | $23.30 M(+35.3%) |
| June 2015 | - | $1.21 M(+7.7%) | $17.23 M(-4.2%) |
| Mar 2015 | - | $1.12 M(-89.6%) | $17.97 M(-18.4%) |
| Dec 2014 | $22.03 M(-501.8%) | $10.74 M(+158.3%) | $22.03 M(+161.5%) |
| Sept 2014 | - | $4.16 M(+112.8%) | $8.43 M(+219.6%) |
| June 2014 | - | $1.95 M(-62.3%) | $2.64 M(-31.3%) |
| Mar 2014 | - | $5.18 M(-280.8%) | $3.84 M(-170.0%) |
| Dec 2013 | -$5.48 M(-78.3%) | -$2.87 M(+75.7%) | -$5.48 M(-5.2%) |
| Sept 2013 | - | -$1.63 M(-151.7%) | -$5.78 M(-49.9%) |
| June 2013 | - | $3.16 M(-176.2%) | -$11.53 M(-46.9%) |
| Mar 2013 | - | -$4.15 M(+31.0%) | -$21.74 M(-14.0%) |
| Dec 2012 | -$25.28 M | -$3.16 M(-57.1%) | -$25.28 M(-23.5%) |
| Sept 2012 | - | -$7.38 M(+4.8%) | -$33.04 M(-13.6%) |
| June 2012 | - | -$7.05 M(-8.4%) | -$38.24 M(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$7.69 M(-29.6%) | -$45.09 M(-5.8%) |
| Dec 2011 | -$47.87 M(+19.4%) | -$10.93 M(-13.2%) | -$47.87 M(-6.4%) |
| Sept 2011 | - | -$12.58 M(-9.4%) | -$51.15 M(+3.5%) |
| June 2011 | - | -$13.89 M(+32.6%) | -$49.42 M(+11.3%) |
| Mar 2011 | - | -$10.47 M(-26.3%) | -$44.41 M(+10.8%) |
| Dec 2010 | -$40.10 M(+117.6%) | -$14.20 M(+30.9%) | -$40.10 M(+25.2%) |
| Sept 2010 | - | -$10.85 M(+22.2%) | -$32.03 M(+28.6%) |
| June 2010 | - | -$8.88 M(+44.1%) | -$24.91 M(+23.7%) |
| Mar 2010 | - | -$6.16 M(+0.4%) | -$20.13 M(+9.2%) |
| Dec 2009 | -$18.43 M(+18.6%) | -$6.14 M(+64.6%) | -$18.43 M(+24.9%) |
| Sept 2009 | - | -$3.73 M(-9.2%) | -$14.75 M(-13.0%) |
| June 2009 | - | -$4.11 M(-7.9%) | -$16.96 M(-3.3%) |
| Mar 2009 | - | -$4.46 M(+81.4%) | -$17.54 M(+12.9%) |
| Dec 2008 | -$15.54 M(-2199.4%) | -$2.46 M(-58.6%) | -$15.54 M(+31.9%) |
| Sept 2008 | - | -$5.93 M(+26.7%) | -$11.78 M(+48.7%) |
| June 2008 | - | -$4.68 M(+90.4%) | -$7.92 M(+50.1%) |
| Mar 2008 | - | -$2.46 M(-289.8%) | -$5.28 M(-813.0%) |
| Dec 2007 | $740.00 K(-114.8%) | $1.30 M(-162.6%) | $739.90 K(+18.7%) |
| Sept 2007 | - | -$2.07 M(+1.6%) | $623.40 K(-53.8%) |
| June 2007 | - | -$2.04 M(-157.4%) | $1.35 M(+59.0%) |
| Mar 2007 | - | $3.56 M(+201.3%) | $848.30 K(-117.0%) |
| Dec 2006 | -$5.00 M(-39.8%) | $1.18 M(-187.6%) | -$5.00 M(-32.0%) |
| Sept 2006 | - | -$1.35 M(-47.0%) | -$7.35 M(-5.5%) |
| June 2006 | - | -$2.54 M(+10.9%) | -$7.78 M(-2.0%) |
| Mar 2006 | - | -$2.29 M(+94.6%) | -$7.94 M(-4.3%) |
| Dec 2005 | -$8.30 M(-20.5%) | -$1.18 M(-33.6%) | -$8.30 M(-21.9%) |
| Sept 2005 | - | -$1.77 M(-34.4%) | -$10.62 M(-8.3%) |
| June 2005 | - | -$2.70 M(+2.0%) | -$11.58 M(+2.9%) |
| Mar 2005 | - | -$2.65 M(-24.4%) | -$11.26 M(+7.8%) |
| Dec 2004 | -$10.44 M(+89.1%) | -$3.50 M(+28.3%) | -$10.44 M(+25.5%) |
| Sept 2004 | - | -$2.73 M(+14.8%) | -$8.32 M(+15.8%) |
| June 2004 | - | -$2.38 M(+29.7%) | -$7.19 M(+22.2%) |
| Mar 2004 | - | -$1.83 M(+32.6%) | -$5.88 M(+6.5%) |
| Dec 2003 | -$5.52 M(+39.4%) | -$1.38 M(-13.3%) | -$5.52 M(+23.9%) |
| Sept 2003 | - | -$1.59 M(+48.4%) | -$4.46 M(+17.8%) |
| June 2003 | - | -$1.07 M(-27.0%) | -$3.78 M(-8.0%) |
| Mar 2003 | - | -$1.47 M(+364.6%) | -$4.11 M(+3.8%) |
| Dec 2002 | -$3.96 M(+117.3%) | -$316.80 K(-65.6%) | -$3.96 M(-21.1%) |
| Sept 2002 | - | -$920.30 K(-34.4%) | -$5.02 M(+63.7%) |
| June 2002 | - | -$1.40 M(+6.2%) | -$3.07 M(+30.0%) |
| Mar 2002 | - | -$1.32 M(-3.8%) | -$2.36 M(+29.4%) |
| Dec 2001 | -$1.82 M(-42.1%) | -$1.37 M(-233.1%) | -$1.82 M(+81.8%) |
| Sept 2001 | - | $1.03 M(-248.3%) | -$1.00 M(-63.2%) |
| June 2001 | - | -$696.10 K(-11.4%) | -$2.73 M(-21.5%) |
| Mar 2001 | - | -$785.70 K(+41.9%) | -$3.47 M(+10.3%) |
| Dec 2000 | -$3.15 M(+76.2%) | -$553.60 K(-20.0%) | -$3.15 M(+21.3%) |
| Sept 2000 | - | -$692.00 K(-52.0%) | -$2.60 M(+36.3%) |
| June 2000 | - | -$1.44 M(+212.9%) | -$1.90 M(+312.9%) |
| Mar 2000 | - | -$461.20 K | -$461.20 K |
| Dec 1999 | -$1.79 M(-41.2%) | - | - |
| Dec 1998 | -$3.04 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual CFO year-on-year change?
- What is ANI Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly CFO year-on-year change?
- What is ANI Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM CFO year-on-year change?
What is ANI Pharmaceuticals annual cash flow from operations?
The current annual CFO of ANIP is $118.96 M
What is the all time high annual CFO for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual cash flow from operations is $118.96 M
What is ANI Pharmaceuticals annual CFO year-on-year change?
Over the past year, ANIP annual cash flow from operations has changed by +$150.16 M (+481.24%)
What is ANI Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ANIP is $12.47 M
What is the all time high quarterly CFO for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly cash flow from operations is $44.74 M
What is ANI Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ANIP quarterly cash flow from operations has changed by -$19.70 M (-61.22%)
What is ANI Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ANIP is $92.90 M
What is the all time high TTM CFO for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM cash flow from operations is $118.96 M
What is ANI Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ANIP TTM cash flow from operations has changed by +$23.08 M (+33.05%)